Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Oncology

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdr022PMID 21427063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFR

  2010cited by this paper
• Metastatic behavior of breast cancer subtypes.

  2010cited by this paper
• Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.

  2010cited by this paper
• Long-term survivors among breast cancer patients with brain metastases.

  2010influential reference
• The role of immunohistochemistry in the differential diagnosis of breast lesions.

  2009cited by this paper
• Survival among women with triple receptor-negative breast cancer and brain metastases.

  2009cited by this paper
• Genes that mediate breast cancer metastasis to the brain

  2009cited by this paper
• Identification of brain- and bone-specific breast cancer metastasis genes.

  2009cited by this paper
• Risk factors for brain relapse in HER2-positive metastatic breast cancer patients

  2009cited by this paper
• Biological pathways contributing to organ-specific phenotype of brain metastatic cells.

  2008cited by this paper
• The influence of basal phenotype on the metastatic pattern of breast cancer.

  2008cited by this paper
• Brain metastases in breast cancer: prognostic factors and management

  2008cited by this paper
• Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer

  2008cited by this paper
• Brain Metastases of Breast Cancer

  2007cited by this paper
• Treatment and prognosis of brain metastases from breast cancer

  2007cited by this paper
• Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

  2007influential reference
• Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis

  2007influential reference
• A Patient Perspective on Brain Metastases in Breast Cancer

  2007cited by this paper
• Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype

  2007cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2007cited by this paper
• Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

  2006cited by this paper
• Primary breast cancer phenotypes associated with propensity for central nervous system metastases

  2006cited by this paper
• Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR

  2006influential reference
• p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer

  2005cited by this paper
• E‐cadherin expression in invasive non‐lobular carcinoma of the breast and its prognostic significance

  2005cited by this paper
• Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

  2005cited by this paper
• Brain metastases from breast cancer: identification of a high-risk group.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Risk factors for brain relapse in patients with metastatic breast cancer.

  2004cited by this paper
• Central nervous system metastases in women after multimodality therapy for high risk breast cancer

  2004cited by this paper
• CNS metastases in breast cancer.

  2004cited by this paper
• Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.

  2003cited by this paper
• Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

  2003cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Brain metastases in breast cancer: prognostic factors and management.

  1999influential reference
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• The distribution of secondary growths in cancer of the breast. 1889.

  1989cited by this paper
• Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

  1987cited by this paper

• Voxel-wise analysis of brain metastasis predilection sites in breast cancer by clinical features

  2025cites this paper
• Brain metastasis risk prediction model in females with hormone receptor-positive breast cancer.

  2024cites this paper
• Receptor discordance among primary tumors, brain metastases and extra-brain metastases in patients with breast cancer.

  2023cites this paper
• Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor

  2023cites this paper
• Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases

  2023cites this paper
• Association Between Primary Tumour-Brain Metastasis Receptor Status Mismatch and Outcomes in Breast Cancer Brain Metastasis

  2023cites this paper
• Molecular aspects of brain metastases in breast cancer.

  2023cites this paper
• Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain

  2022cites this paper
• Overview of Patients with Metastatic Brain Tumors from Breast Cancer at H. Adam Malik Hospital, Medan in 2017-2021

  2021cites this paper
• Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance

  2021cites this paper
• Risk factors for breast cancer brain metastases: a systematic review

  2020influential citation
• Colonic Metastases from a Luminal A Type Invasive Ductal Carcinoma Breast: A Rare Case Report

  2020cites this paper
• FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients

  2020cites this paper
• Subtype switching in breast cancer brain metastases: a multicenter analysis

  2020cites this paper
• Estrogen, Progesterone and HER2 Receptor Discordance Between Primary Tumor and Brain Metastases in Breast Cancer and Its Effect on Treatment and Survival.

  2020cites this paper
• Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients

  2020cites this paper
• Epidemiology of Central Nervous System Metastases

  2019cites this paper
• Profiles of brain metastases: Prioritization of therapeutic targets

  2018cites this paper
• Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis

  2018influential citation
• Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis

  2017cites this paper
• Comprehensive molecular biomarker identification in breast cancer brain metastases

  2017cites this paper
• Importancia de los niveles de vitamina d en la prevención secundaria de la osteoporosis corticoidea

  2017cites this paper
• Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy.

  2017cites this paper
• A Case of Breast Cancer Brain Metastasis with a 16-Year Time Interval without Evidence of Cancer Recurrence

  2017cites this paper
• Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review

  2016cites this paper
• Androgen Receptor and Enzymes in Lymph Node Metastasis and Cancer Reoccurrence in Triple-Negative Breast Cancer

  2015cites this paper
• Gene expression in “young adult type” breast cancer: a retrospective analysis

  2015cites this paper
• Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

  2015cites this paper
• KRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosis.

  2015cites this paper
• Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.

  2015cites this paper
• CNS metastases in breast cancer patients: prognostic implications of tumor subtype

  2014cites this paper
• Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

  2014cites this paper
• 18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment

  2014cites this paper
• miRNAs and Target Genes in Breast Cancer Metastasis

  2014cites this paper
• Clinical Perspectives: Breast Cancer Brain Metastasis

  2014cites this paper
• Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51.

  2013cites this paper
• 37PBRAIN METASTASES IN TRIPLE RECEPTOR-NEGATIVE BREAST CANCER: FREQUENCY, RISK GROUPS AND PROGNOSIS

  2013cites this paper
• Clinical Trials for Breast Cancer with Brain Metastases: Challenges and New Directions

  2013cites this paper
• Circulating Tumor Cells and Extracellular Nucleic Acids in Breast Cancer

  2012cites this paper
• Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.

  2012cites this paper
• Studies of ionic mechanisms associated with human cancers

  2012cites this paper
• Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain

  2012cites this paper
• DISEASE-FREE SURVIVAL OF BREAST CANCER PATIENTS AND IDENTIFICATION OF RELATED FACTORS

  2011cites this paper
• Scholarly Commons @ Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida

  year unknowncites this paper
• Breast Cancer to Brain Metastases unknown Reboot until Trauma: A Case Report and Literature Review

  year unknowncites this paper